Severe pulmonary hypertension possibly due to pyrrolizidine alkaloids in polyphytotherapy

Swiss Medical Weekly

Volumn 139, Issue 13-14, 2009, Pages 210-211

  Györik, Sándor ^a   Stricker, Hans ^b  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b Ospedale La Carita   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ILOPROST; NIFEDIPINE; PYRROLIZIDINE ALKALOID; SILDENAFIL;

AGED; BREATHING RATE; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FOOT ULCER; HUMAN; LETTER; LIVER PAIN; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; OXYGEN THERAPY; PHYTOTHERAPY; PULMONARY HYPERTENSION; TOTAL LUNG CAPACITY; VERTIGO;

EID: 65249163699     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (20)

1. Gyorik SA, Brutsche MH. Complementary and alternative medicine for bronchial asthma: is there new evidence? Curr Opin Pulm Med. 2004;10(1):37-43.
2. Goldstein LH, Elias M, Ron-Avraham G, et al. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol. 2007;64 (3):373-80.
3. Cuzzolin L, Zaffani S, Benoni G. Safety implications regarding use of phytomedicines. Eur J Clin Pharmacol. 2006;62(1):37-42.
4. Corns C, Metcalfe K. Risks associated with herbal slimming remedies. J R Soc Health. 2002; 122(4):213-9.
5. Souza R, Humbert M, Sztrymf B, et al. Pulmonary arterial hypertension associated with fenfuramine exposure: report of 109 cases. Eur Respir J. 2008;31(2):343-8.
6. Widgren S. Pulmonary hypertension related to aminorex intake. Histological, ultrastructural, and morphometric studies of 37 cases in Switzerland. Curr T o p Pathol. 1977;64:1-64.
7. Jordan MA, Haywood T. Evaluation of internet websites marketing herbal weight-loss supplements to consumers. J Altern Complement Med. 2007;13(9):1035-43.
8. Weston CF, Cooper BT, Davies JD, Levine DF. Ve no-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J. (Clin Res Ed) 1987;295(6591):183.
9. Stickel F, Seitz HK. The effcacy and safety of comfrey. Public Health Nutr. 2000;3(4A):501-8.
10. Bach N, Thung SN, Schaffner F. Comfrey herb tea-induced hepatic veno-occlusive disease.Am J Med. 1989;87(1):97-9.
11. Ridker PM, Ohkuma S, McDermott WV, Trey C, Huxtable RJ. Hepatic venocclusive disease associated with the consumption of pyrrolizidinecontaining dietary supplements. Gastroenterology. 1985;88(4):1050-4.
12. Kay JM, Heath D. Observations on the pulmonary arteries and heart weight of rats fed on Crotalaria spectabilis seeds. J Pathol Bacteriol. 1966;92(2):385-94.
13. Kay JM, Harris P, Heath D. Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax. 1967;22(2): 176-9.
14. Chesney CF, Allen JR. Animal model: pulmonary hypertension, cor pulmonale and endocardial fbroelastosis in monocrotaline-intoxicated nonhuman primates. Am J Pathol. 1973;70 (3):489-92.
15. Stewart MJ, Steenkamp V. Pyrrolizidine poisoning: a neglected area in human toxicology. Ther Drug Monit. 2001;23(6):698-708.
16. Steenkamp V, Stewart MJ, Zuckerman M. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther Drug Monit 2000;22(3):302-6.
17. Heath D, Shaba J, Williams A, Smith P, Kombe A. A pulmonary hypertension-producing plant from Ta nzania. Thorax. 1975;30(4):399-404.
18. Olson JW, Atkinson JE, Hacker AD, Altiere RJ, Gillespie MN. Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary oedema and arterial medial thickening. T o xicol Appl Pharmacol. 1985;81(1):91-9.
19. Bartsch P, Mairbaurl H, Swenson ER, Maggiorini M. High altitude pulmonary oedema. In: Swiss Med Wkly. 2003:377-84.
20. Egermayer P. Epidemics of vascular toxicity and pulmonary hypertension: what can be learned? J Intern Med. 2000;247(1):11-7.